Table 2.
GCDFP-15 and MAM expression in metastatic/recurrent TNBC at different organ sites.
| Site | No. of cases | GCDFP-15 | MAM | ||
|---|---|---|---|---|---|
|
| |||||
| Positive | Negative | Positive | Negative | ||
|
| |||||
| Chest wall soft tissue recurrence | 5 | 2 | 2 | 1 | 3 |
|
| |||||
| Chest wall/breast skin recurrence | 4 | 2 | 2 | 0 | 2 |
|
| |||||
| Regional lymph node metastasis | 14 | 3 | 10 | 4 | 5 |
|
| |||||
| Distant metastasis | |||||
| Lung | 44 | 3 | 37 | 10 | 13 |
| Liver | 17 | 3 | 12 | 7 | 5 |
| Soft tissuea | 8 | 0 | 8 | 0 | 3 |
| Bone | 7 | 3 | 4 | 1 | 2 |
| Distant lymph node | 5 | 2 | 3 | 0 | 1 |
| Brain | 4 | 3 | 1 | 2 | 0 |
| Ovary | 3 | 1 | 2 | 0 | 1 |
| Bladder | 2 | 0 | 2 | 0 | 2 |
| GI tract | 2 | 0 | 2 | 0 | 1 |
| Skin (abdomen) | 1 | 0 | 1 | 0 | 0 |
| Trachea | 1 | 0 | 1 | 1 | 0 |
| Uterus | 1 | 1 | 0 | 0 | 0 |
|
| |||||
| Total | 118 | 23 (21%) | 87 | 26 (41%) | 38 |
a
Soft tissue sites include neck (×2), mediastinum (×2), pelvis, back, shoulder, and axilla.